Paloma Partners Management Co Invests $1.37 Million in Avantor, Inc. (NYSE:AVTR)

Paloma Partners Management Co purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 52,761 shares of the company's stock, valued at approximately $1,365,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. 1832 Asset Management L.P. raised its stake in shares of Avantor by 1,634.9% in the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company's stock valued at $180,839,000 after acquiring an additional 8,038,451 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in Avantor by 653.0% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock valued at $159,740,000 after purchasing an additional 5,354,678 shares during the last quarter. FMR LLC raised its position in Avantor by 557.2% in the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company's stock valued at $120,950,000 after purchasing an additional 3,963,912 shares during the last quarter. Sound Shore Management Inc. CT acquired a new position in Avantor in the second quarter worth $76,412,000. Finally, Principal Financial Group Inc. grew its holdings in shares of Avantor by 146.5% during the third quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company's stock worth $67,996,000 after purchasing an additional 1,562,018 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently issued reports on AVTR shares. Robert W. Baird cut their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a report on Monday, October 28th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. UBS Group decreased their price target on shares of Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, October 8th. Barclays dropped their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a research report on Friday, October 25th. Finally, Wells Fargo & Company decreased their price objective on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research report on Monday, October 28th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $27.57.

Avantor Trading Down 0.0 %

Shares of Avantor stock traded down $0.01 during trading on Tuesday, hitting $21.09. 4,051,413 shares of the company were exchanged, compared to its average volume of 6,647,807. The firm has a market capitalization of $14.35 billion, a P/E ratio of 45.85, a price-to-earnings-growth ratio of 2.56 and a beta of 1.29. The firm's fifty day moving average price is $23.06 and its 200 day moving average price is $23.66. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor, Inc. has a 1-year low of $19.59 and a 1-year high of $28.00.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.